Alpha-melanocyte-stimulating hormone contributes to an anti-inflammatory response to lipopolysaccharide

R P Reynolds1, R R Fan1, A Tinajero1

  • 1Department of Internal Medicine, Center for Hypothalamic Research, Dallas, TX, USA.

Molecular Metabolism
|July 11, 2024
PubMed
Abstract

Insights

Endogenous alpha-melanocyte-stimulating hormone (α-MSH) is crucial for regulating immune responses to bacterial lipopolysaccharide (LPS). Mice lacking α-MSH exhibit exaggerated inflammation and metabolic dysfunction, highlighting its role in controlling inflammatory conditions.

Area of Science:

  • Immunology and Metabolism
  • Neuroendocrinology

Background:

  • Pro-opiomelanocortin (POMC) cleavage products, including α-MSH, are released in the brain and pituitary.
  • α-MSH regulates energy balance and possesses anti-inflammatory properties, but its role in physiological anti-inflammatory responses is unclear.
  • A novel mouse model (Pomctm1/tm1) was developed to investigate the function of endogenous α-MSH.

Purpose of the Study:

  • To determine if endogenous α-MSH is required for regulating immune responses during acute inflammation.
  • To compare the inflammatory and metabolic responses to lipopolysaccharide (LPS) between mice with and without α-MSH production.

Main Methods:

  • Male Pomctm1/tm1 and wild-type Pomcwt/wt mice were injected with saline or low-dose LPS.
  • Immune and metabolic parameters were monitored, including core body temperature, circulating cytokines, corticosterone, and α-MSH levels.
  • Measurements included body weight, food intake, activity, respiration, and hypothalamic/pituitary α-MSH concentrations via mass spectrometry.

Main Results:

  • Pomctm1/tm1 mice showed an exaggerated immune response to LPS compared to controls.
  • Mice lacking α-MSH experienced more severe hypothermia, reduced oxygen consumption, and impaired metabolic responses post-LPS.
  • Elevated pro-inflammatory cytokines were observed in Pomctm1/tm1 mice, while wild-type mice showed increased circulating α-MSH after LPS.

Conclusions:

  • Endogenous α-MSH plays a significant role in modulating inflammatory immune responses to LPS.
  • Targeting the melanocortin system may offer a therapeutic strategy for treating sepsis and inflammatory diseases.
  • These findings underscore the link between metabolism and immunity regulated by the POMC system.